Literature DB >> 781314

Immunologic considerations in renovascular hypertension.

J J Kaufman, R M Ehrlich, L Dornfeld.   

Abstract

For decades certain diseases, such as glomerulonephritis, polyarteritis nodosa, scleroderma and serum sickness, have been linked with autoimmune pathogenesis. During recent years a host of additional diseases traditionally thought to have some genetic predisposition but with obscure etiology have been suspected of being autoimmune in nature. Rheumatoid arthritis, diabetes, myasthenia gravis and thyroiditis are diseases of widely divergent organ systems, yet may well have common pathways of pathology via immune complexing mechanisms. Herein we present evidence supporting the concept that renal artery stenosis (occurring primarily in association with the middle aortic syndrome or after renal transplantation) is of immune etiology. Although the specific antigenic agent is still to be defined there is growing acceptance of the theory that medium and large vessels are subject to autoimmune vasculitis in many aspects similar to the autoimmune affections of small vessels. Several cases are presented. Some of these suggest an immune reaction by the natural history but without evidence of immunochemical reactants in the involved vessels, presumably because active disease was arrested at the time of study. In other cases immunofluorescent preparations demonstrate reactants in the walls of the vessels to document the hypothesis more convincingly.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 781314     DOI: 10.1016/s0022-5347(17)58724-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

Review 1.  Hypertension and facial palsy in middle aortic syndrome.

Authors:  V E Lewis; D S Peat; E J Tizard
Journal:  Arch Dis Child       Date:  2001-09       Impact factor: 3.791

2.  Renal artery stenosis in pediatric transplant recipients.

Authors:  M Malekzadeh; C M Grushkin; P Stanley; L P Brennan; Q R Stiles; E Lieberman
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.